Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines

FEBS Journal

Volumn 278, Issue 18, 2011, Pages 3360-3369

  Fallahian, Faranak ^a   Karami Tehrani, Fatemeh ^a   Salami, Siamak ^b   Aghaei, Mahmoud ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

apoptosis; cyclic guanosine 3,5 monophosphate (cGMP); MCF 7; MDA MB 468; protein kinase G

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; ESTROGEN RECEPTOR; ISOENZYME; KT 5823; LIFICIGUAT;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL STRAIN MCF 7; CELL STRAIN MDA MB 468; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATORS; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANYLATE CYCLASE; HUMANS; INHIBITORY CONCENTRATION 50; ISOENZYMES; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; PROTEIN KINASE INHIBITORS; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 80052441173     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08260.x     Document Type: Article

References (32)

1. Eigenthaler M, Lohmann SM, Walter U, &, Pilz RB, (1999) Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression. Rev Physiol Biochem Pharmacol 135, 173-209.
2. Smolenski A, Burkhardt AM, Eigenthaler M, Butt E, Gambaryan S, Lohmann SM, &, Walter U, (1998) Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn-Schmiedebergs Arch Pharmacol 358, 134-139.
3. Vaandrager AB, &, De Jonge HR, (1996) Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 157, 23-30.
4. Loweth AC, Williams GT, Scarpello JNB, &, Morgan NG, (1997) Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett 400, 285-288.
5. Shimojo T, Hiroe M, Ishiyama S, Ito H, Nishikawa T, &, Marumo F, (1999) Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp Cell Res 247, 38-47.
6. Kimberly AL, Giovanni MP, Kazerounian S, &, Ruiz-Stewart I, (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52, 375-413.
7. Stacey P, Rulten S, Dapling A, &, Phillips SC, (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247, 249-254.
8. Torphy TJ, (1998) Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157, 351-370.
9. Hofmann F, (2005) The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280, 1-4.
10. Kaupp UB, &, Seifert R, (2002) Cyclic nucleotide-gated ion channels. Physiol Rev 82, 769-824.
11. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, &, Hofmann F, (1999) Structure and function of cGMP-dependentprotein kinases. Rev Physiol Biochem Pharmacol 135, 105-149.
12. Ruth P, (1999) Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol Ther 82, 355-372.
13. Lohmann SM, Fischmeister R, &, Walter U, (1991) Signal transduction by cGMP in heart. Basic Res Cardiol 86, 503-514.
14. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, &, De Jonge HR, (1997) Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 22, 307-312.
15. Uhler MD, (1993) Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J Biol Chem 268, 13586-13591.
16. Lincoln TM, Dey N, &, Sellak H, (2001) Signal transduction in smooth muscle-Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91, 1421-1430.
17. Kaminski A, Gao H, &, Morgan NG, (2004) Involvement of the cGMP signalling pathway in the regulation of viability in insulin-secreting BRIN-BD11 cells. FEBS Lett 559, 118-124.
18. Browning DD, (2008) Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer. Expert Opin Biol Ther 8, 1-10.
19. Browning DD, (2010) CGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment. Future Med Chem 2, 65-80.
20. Deguchi A, Thompson WJ, &, Weinstein IB, (2004) Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res 64, 3966-3973.
21. Hou Y, Gupta N, Schoenlein P, Wong E, Martindale R, Ganapathy V, &, Browning DD, (2006) An anti-tumor role for cGMP-dependent protein kinase. Cancer Lett 240, 60-68.
22. Liu L, Li H, Underwood T, Loyd M, David M, Sperl G, Pamukcu R, &, Thompson WJ, (2001) Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther 299, 583-592.
23. Pitari GM, Li T, Baksh RI, &, Waldman SA, (2006) Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells. Mol Cancer Ther 5, 1190-1196.
24. Deguchi A, Das KK, Xing SW, Oehlen B, &, Weinstein IB, (2005) Down-regulation of the cGMP/PKG pathway in primary human colon cancer s and cancer cell lines. Proc Am Assoc Cancer Res 46, 56-68.
25. Wu CC, Ko FN, Kuo SC, Lee FY, &, Teng CM, (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116, 1973-1978.
26. Zaitsev SV, Appelskog IB, Kapelioukh IL, &, Yang SN, (2001) Imidazoline compounds protect against IL-1-induced -cell apoptosis. Diabetes 50, 70-76.
27. Hadjivassiliou V, Green MH, James RF, Swift SM, Clayton HA, &, Green IC, (1998) Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide 2, 429-441.
28. Ferrero R, &, Torres M, (2001) Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism. Neuropharmacology 41, 895-906.
29. Yao-Ting H, Shiow-Lin P, Jih-Hwa G, Ya-Ling C, Fang-Yu L, Sheng-Chu K, &, Che-Ming T, (2005) YC-1 suppresses constitutive nuclear factor-KB activation and induces apoptosis in human prostate cancer cells. Mol Cancer Ther 4, 1628-1635.
30. Hsu HK, Juan SH, Ho PY, Liang YC, Lin CH, Teng CM, &, Lee WS, (2003) YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway. Biochem Pharmacol 66, 263-271.
31. Wang SW, Pan SL, Guh JH, Chen HL, Huang DM, Chang YL, Kuo SC, Lee FY, &, Teng CM, (2005) YC-1 [3-(5-Hydroxymethyl-2-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. J Pharmacol Exp Ther 312, 917-925.
32. Janicke RU, Sprengart ML, Wati MR, &, Porter AG, (1998) Caspase-3 required for DNA fragmentation, and morphological changes associated with apoptosis. J Biol Chem 273, 9357-9360.